title: Older patients with schizophrenia: challenges in the coming decades.
abstract: The number and proportion of older adults with schizophrenia will increase considerably in the coming decades. Although a vast literature on schizophrenia among younger adults exists, much less is known about late-life schizophrenia and its treatment. The authors describe two potential scenarios for 2011, the year that the first baby boomers will turn 65. To ensure that the more favorable scenario becomes a reality, the authors suggest four goals: decrease medical comorbidity and mortality among younger patients with schizophrenia and improve their access to health care so that they can live longer and more productive lives; improve our understanding of the neurobiological and psychosocial factors underlying late-life schizophrenia, as well as the health care and social service needs of such patients; develop more effective and safer pharmacologic, psychosocial, and cognitive behavioral treatments; and improve rehabilitation of older people with schizophrenia. Specific strategies to foster these goals include establishing a consortium for studies of late-life schizophrenia; conducting multicenter studies of treatment effectiveness; and forming interdisciplinary collaborations among researchers, clinicians, government and industry representatives, and patient advocacy groups.
authors.affiliation: Department of Psychiatry at the University of California, San Diego, USA. bpalmer@ucsd.edu
authors.forename: B W
authors.initials: BW
authors.lastname: Palmer
authors.forename: S C
authors.initials: SC
authors.lastname: Heaton
authors.forename: D V
authors.initials: DV
authors.lastname: Jeste
mesh_terms: D000368:Aged; D005544:Forecasting; D006301:Health Services Needs and Demand / Q000639:trends; D006299:Health Services for the Aged / Q000191:economics / Q000592:standards / Q000639:trends*; D006801:Humans; D008605:Mental Health Services / Q000191:economics / Q000592:standards / Q000639:trends*; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000175:diagnosis / Q000191:economics / Q000628:therapy*; D012565:Schizophrenic Psychology; D014481:United States